Abercrombie & Fitch to see earnings ‘upside,’ but there’s potential margin pressure ahead: analyst

Date:

August 27, 2024

Abercrombie & Fitch Co. is expected to deliver sales growth ahead of its forecasts when it reports second-quarter results on Wednesday after a strong stock-price performance, William Blair analyst Dylan Carden said in a research note.

Source link

Fans Are Campaigning for Sam Not to Be Killed Off 'General Hospital'

Angelina Jolie's Venice Film Festival Arrival Goes All In On Fall Style

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Abercrombie & Fitch to see earnings ‘upside,’ but there’s potential margin pressure ahead: analyst

Recent posts

Harris-Trump debate: How the U.S. election may impact bitcoin and other crypto prices

Wall Street is going all-in on election betting markets. What you need to know.

Zenas BioPharma sets price range for $200 million initial public offering

What an August election-year rally for stocks could mean for Wall Street’s ‘Great Rotation’

Eli Lilly’s Alzheimer’s drug wins FDA approval

Bud Light sales extend their drop but Michelob Ultra takes up some slack: report

Consumer sentiment improves for third straight month, as expectations for the economy brighten

Oil prices on track for 4th straight weekly gain

Oil prices edge lower but supply concerns over Libya, Middle East still linger

Boeing’s confidence in Starliner ‘speaks volumes,’ says former NASA astronaut

Harris campaign blasts Trump’s tariffs, as he hits her over how she’ll fund her economic plans

Dogecoin soars as altcoins look to benefit from Trump presidency

Harris trades: These healthcare stocks could rally if she wins — or drop if Trump triumphs

Oil turns higher for the week after hurricane Francine landfall

Oil prices remain lower amid Gaza ceasefire hopes as investors prepare for PCE data

Related articles

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Manufacturing activity surges in New York region to highest level in nearly three years

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Company

Follow us